Many dog owners have already heard about the FDA warning and seen the articles on the terrible side effects experienced by ...
Obesity continues to grab attention at the J.P. Morgan Healthcare Conference in San Francisco, with both Pfizer and Kailera ...
Compared with AS alone, coexisting ATTR-CA was associated with an increased risk of mortality (HR 1.3, 95% CI 1.1-1.4) in a ...
Citi analyst Geoff Meacham maintained a Hold rating on Pfizer (PFE – Research Report) today. The company’s shares closed yesterday at ...
Bernstein analyst Courtney Breen maintained a Hold rating on Pfizer (PFE – Research Report) today and set a price target of $32.00. The ...
High-yield dividend stocks may not appeal to some investors. However, if you're among those investors looking for income, ...
Leading biopharmaceutical company Pfizer has unveiled Cibinqo and Staquis, two innovative therapies designed to address eczema across its varying stages, now available in Malaysia. The announcement, ...
These companies headline a $1.4 trillion industry, have staying power, and will pay you well to hold their stock.
The U.S. government has selected the second batch of drugs up for Medicare price negotiations under the Inflation Reduction ...
The US plans to slash the price it pays for the Novo Nordisk A/S blockbusters Ozempic and Wegovy, the latest drugs to be ...
The US plans to slash the price it pays for the Novo Nordisk A/S blockbusters Ozempic and Wegovy, the latest drugs to be ...
Life-changing gene therapies for hemophilia have become available, yet many patients and providers have not yet rushed to try ...